ESC Professional Premium Access

Great Debate: device-detected subclinical AF should be treated like clinical AF. All patients with HF and AF should undergo AF ablation

Event: ESC Congress 2022
Topic: Stroke Treatment
Session type: Great Debates
Date: 27 August 2022
Time: 08:30 - 10:00

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

6 presentations in this session

Device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation: pro.

Speaker: Professor G. Boriani (Modena, IT)
Thumbnail

Device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation: con.

Speaker: Professor I. Van Gelder (Groningen, NL)
Thumbnail

Device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation – the final word.

Thumbnail

All patients with heart failure and atrial fibrillation should undergo atrial fibrillation ablation: pro.

Speaker: Professor L. Di Biase (New York, US)
Thumbnail

All patients with heart failure and atrial fibrillation should undergo atrial fibrillation ablation: con.

Speaker: Doctor A. Verma (Montreal, CA)
Thumbnail

All patients with heart failure and atrial fibrillation should undergo atrial fibrillation ablation – the final word.

Thumbnail

4 speakers from this session

Professor Giuseppe Boriani

Modena Polyclinic Modena University Hospital, Modena (Italy)
33 presentations
1 follower

Professor Isabelle C Van Gelder

University Medical Centre Groningen, Groningen (Netherlands (The))
40 presentations
4 followers

Professor Luigi Di Biase

Albert Einstein College of Medicine at Montefiore Hospital, New York (United States of America)
20 presentations
0 follower

Doctor Atul Verma

McGill University Health Centre, Montreal (Canada)
6 presentations
0 follower

This platform is supported by

logo Novo Nordisk